Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck

Overview of attention for article published in Annals of Oncology, April 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 77 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,808 followers.

Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck. https://t.co/tkT5sfxMbR H/T @NCBI #radonc #PubMed

Final Results of a Multi-institutional Phase II Trial of Re-Irradiation with Concurrent Weekly Cisplatin and Cetuximab for Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck. https://t.co/1uzivOW9nR

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.